Comparison of the Respiratory Toxicity and Total Cholinesterase Activities in Dimethyl Versus Diethyl Paraoxon-Poisoned Rats.
cholinesterases
diethyl paraoxon
dimethyl paraoxon
plethysmography
rats
respiratory toxicity
Journal
Toxics
ISSN: 2305-6304
Titre abrégé: Toxics
Pays: Switzerland
ID NLM: 101639637
Informations de publication
Date de publication:
16 Apr 2019
16 Apr 2019
Historique:
received:
26
02
2019
revised:
11
04
2019
accepted:
13
04
2019
entrez:
19
4
2019
pubmed:
19
4
2019
medline:
19
4
2019
Statut:
epublish
Résumé
The chemical structure of organophosphate compounds (OPs) is a well-known factor which modifies the acute toxicity of these compounds. We compared ventilation at rest and cholinesterase activities in male Sprague-Dawley rats poisoned with dimethyl paraoxon (DMPO) and diethyl paraoxon (DEPO) at a subcutaneous dose corresponding to 50% of the median lethal dose (MLD). Ventilation at rest was recorded by whole body plethysmography. Total cholinesterase activities were determined by radiometric assay. Both organophosphates decreased significantly the respiratory rate, resulting from an increase in expiratory time. Dimethyl-induced respiratory toxicity spontaneously reversed within 120 min post-injection. Diethyl-induced respiratory toxicity was long-lasting, more than 180 min post-injection. Both organophosphates decreased cholinesterase activities from 10 to 180 min post-injection with the same degree of inhibition of total cholinesterase within an onset at the same times after injection. There were no significant differences in residual cholinesterase activities between dimethyl and diethyl paraoxon groups at any time. The structure of the alkoxy-group is a determinant factor of the late phase of poisoning, conditioning duration of toxicity without significant effects on the magnitude of alteration of respiratory parameters. For same duration and magnitude of cholinesterase inhibition, there was a strong discrepancy in the time-course of effects between the two compounds.
Identifiants
pubmed: 30995784
pii: toxics7020023
doi: 10.3390/toxics7020023
pmc: PMC6631413
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Br J Pharmacol Chemother. 1953 Dec;8(4):466-75
pubmed: 13115640
Arch Biochem Biophys. 1955 Feb;54(2):569-71
pubmed: 14350811
Int J Epidemiol. 2003 Dec;32(6):902-9
pubmed: 14681240
Clin Evid. 2005 Jun;(13):1744-55
pubmed: 16135310
Lancet. 2005 Oct 22-28;366(9495):1452-9
pubmed: 16243090
Toxicology. 2007 Mar 22;232(1-2):37-49
pubmed: 17250945
Biochem Pharmacol. 2007 Jun 1;73(11):1807-17
pubmed: 17382909
Toxicol Appl Pharmacol. 2008 Dec 1;233(2):186-92
pubmed: 18775447
Toxicol Sci. 2010 Aug;116(2):660-72
pubmed: 20498006
Neurosci Biobehav Rev. 1991 Spring;15(1):47-50
pubmed: 2052197
Crit Care Med. 2011 Apr;39(4):803-11
pubmed: 21242797
Toxicology. 2012 Apr 11;294(2-3):94-103
pubmed: 22365945
Toxicol Lett. 2012 Sep 3;213(2):142-50
pubmed: 22728148
Chin Med J (Engl). 2012 Oct;125(20):3612-8
pubmed: 23075712
Anal Biochem. 1975 Mar;64(1):229-38
pubmed: 237428
Ann Pharm Fr. 2016 May;74(3):173-89
pubmed: 27107462
J Affect Disord. 2017 Sep;219:93-104
pubmed: 28535450
J Med Toxicol. 2018 Mar;14(1):91-98
pubmed: 29230717
Turk J Anaesthesiol Reanim. 2018 Apr;46(2):131-138
pubmed: 29744248
Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:341-360
pubmed: 30230960
N Engl J Med. 1987 Mar 26;316(13):761-3
pubmed: 3029588
Mil Med. 1987 Jan;152(1):35-41
pubmed: 3103007
Fundam Appl Toxicol. 1985 Feb;5(1):151-7
pubmed: 3987991
Respir Physiol. 1970 Oct;10(3):384-95
pubmed: 5476156